Europe Archives - Page 40 of 93 - Journal for Clinical Studies

Current Edition

Europe

Aimmune’s peanut drug moves closer to European market

An experimental peanut allergy drug from Aimmune Therapeutics has met the primary endpoint of a Phase 3 European study, according to topline data released by the com...

28 March 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease

Approval is based on ODYSSEY OUTCOMES trial of 18,924 patients who recently suffered an acute coronary syndrome such as a heart attackPraluent is the only EU-approve...

21 March 2019 Europe | news | Regional News

Continue Reading →

Europe

CRF Bracket Supports Remote Consenting for Virtual Clinical Studies with Latest Release of its Integrated eConsent Solution

TrialConsent extends informed consent to virtual studies for Sites, Sponsors and Patients London, UK and Philadelphia, USA – March 19, 2019: CRF Bracket anno...

21 March 2019 Europe | news | North America

Continue Reading →

Europe

SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer

DCVAC/OvCa decreased the risk of death in second line treatment of ovarian cancer by 62%Overall survival (OS) increased significantly by 13.4 months. Median Pro...

21 March 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Life Sciences Companies Adopt Veeva Nitro to Eliminate the Burden of Custom Data Warehouse Development and Maintenance

Next-generation commercial data warehouse speeds implementation and automatically syncs with most important data sources BARCELONA, Spain — 19 March 2019—Veeva Sys...

19 March 2019 Europe | news | Regional News

Continue Reading →

Asia Pacific

Takeda’s Entyvio beats AbbVie’s Humira in head-to-head UC study

Takeda's Entyvio outperformed AbbVie's Humira as an ulcerative colitis therapy, according a topline readout of a Phase 3b study by the Japanese pharma.The ...

13 March 2019 Asia Pacific | Europe | news | Regional News

Continue Reading →

Europe

Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials

11 March 2019, East Millstone, N.J. – Envigo, a leading provider of non-clinical contract research services and research models, announced today the launch of PATHWA...

13 March 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

ERYTECH Presents Findings at European Red Cell Research Society Meeting

LYON, France and CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical compa...

13 March 2019 Europe | news | Regional News

Continue Reading →

Europe

Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease

Product is the result of a partnership with Integrated DNA Technologies, and provides clinical-stage clients with a critical raw material. FARGO, ND (March 12, 201...

13 March 2019 Europe | news | Regional News

Continue Reading →

Europe

ECCO 2019: Entyvio set to be most dominant drug in the UC landscape following VARSITY trial, says GlobalData

The results of the VARSITY trial, a head-to-head Phase IIIb double-blind, double-dummy, multicentre, active controlled study, that evaluates the efficacy and safety ...

13 March 2019 Europe | news | Regional News

Continue Reading →